Back
EHRA Premium Access

Incidence and exploratory analysis of cancer development after new on-set atrial fibrillation

Session: ePosters Day 2
Topic: Prevalence and Incidence of Atrial Fibrillation
Speaker: Doctor J. Quesada-Ocete (Valencia, ES)
Event: EHRA 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Javier Quesada-Ocete

GENERAL UNIVERSITY HOSPITAL OF VALENCIA CONSORTIUM, Valencia (Spain)
0 follower

131 more presentations in this session

Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion

Speaker: Doctor L. Sgarra (Acquaviva Delle Fonti, IT)

Access
Abstract
Slides
Like
Thumbnail

Pure and impure tachycardiomiopathy: key differences and long term prognosis

Speaker: Doctor G. Stronati (Ancona, IT)

Access
Abstract
Slides
Like
Thumbnail

Prognostic value of plasma neutrophil gelatinase-associated lipocalin for cardiovascular events in patients with chronic heart failure and atrial fibrillation

Speaker: Professor D. Lashkul (Zaporizhzhya, UA)

Access
Abstract
Slides
Like
Thumbnail

Interatrial block as a prognosticator of new-onset atrial fibrillation: prospective observational study of 8012 adults

Speaker: Mr E. Abdovic (Zenica, BA)

Access
Abstract
Slides
Like
Thumbnail

CHA2DS2-VASc score and the risk of death in atrial fibrillation

Speaker: Doctor A. Aro (Helsinki, FI)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

ePosters Day 2

Speakers: Doctor J. Quesada-Ocete, Doctor L. Sgarra, Doctor G. Stronati, Professor D. Lashkul, Mr E. Abdovic...
Access
Like
Thumbnail

About the event

Image

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources